Both in Surgical Instruments
ResMed vs West Pharmaceutical Services
Over the past year RMD returned −2.4% and WST returned +42.5%; their daily moves had a correlation of 0.21.
RMD −2.4% WST +42.5%Growth of $1, one year, split-adjusted
| Metric | RMD | WST |
|---|---|---|
| Price | $240.51 | $408.78 |
| Market cap | $33.83B | $28.48B |
| Today | +5.91% | +0.44% |
| 1 month | +9.0% | +9.7% |
| 6 months | +14.7% | +30.8% |
| Year to date | −0.1% | +48.6% |
| 1 year | −3.4% | +46.1% |
| Revenue growth (YoY) | +5.9% | +8.7% |
| Gross margin | 61.5% | 39.7% |
| Net margin | 29.6% | 24.5% |
| P/E (TTM) | 21.2× | 44.6× |
| Price / sales | 5.9× | 8.4× |
| Net cash | $601.1M | $261.2M |
| Dividend yield | 1.10% | 0.22% |
| Volatility (60d) | 32.6% | 20.3% |
| Short % of float | 8.5% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).